Literature DB >> 10774294

[Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].

A C Voogd1, M A Crommelin, O J Repelaer van Driel, M C Nolthenius-Puylaert, L H van der Heijden, J W Coebergh.   

Abstract

OBJECTIVE: To analyse the incidence and treatment of ductal carcinoma in situ (DCIS) of the breast in the population.
DESIGN: Retrospective, descriptive.
METHOD: The incidence of DCIS in the period 1975-1997 in 8 hospitals in southeastern North Brabant and northern Limburg, the Netherlands, was analysed, using data from the Eindhoven Cancer Registry. Changes in the treatment of DCIS in the period 1984-1997 were studied, using information from the Breast Cancer Documentation Project.
RESULTS: Between 1975 and 1997, 448 cases of DCIS were detected in 442 women. After adjustment for age according to the European Standard Population, the incidence rate of DCIS increased from 0.3 per 100,000 in 1975 to 13.4 in 1997. Of the 87 patients with DCIS between 50 and 69 years of age in 1996 and 1997, 68% was detected by the screening programme. The proportion of patients with DCIS undergoing ablation of the breast was 53% during the period 1984-1989, and varied around 45% thereafter. The other patients underwent local excision. The proportion of patients receiving radiotherapy after local excision decreased from 78% in the period 1984-1989 to 24% in the period 1994-1995 and rose to 41% during the last few years. Substantial differences in the treatment of DCIS were observed between the 8 hospitals.

Entities:  

Mesh:

Year:  2000        PMID: 10774294

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ.

Authors:  M A J de Roos; G H de Bock; P C Baas; L de Munck; T Wiggers; J de Vries
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

2.  Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.

Authors:  I Soerjomataram; W J Louwman; M J C van der Sangen; R M H Roumen; J W W Coebergh
Journal:  Br J Cancer       Date:  2006-06-27       Impact factor: 7.640

3.  Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.

Authors:  Marnix A de Roos; Bert van der Vegt; Jaap de Vries; Jelle Wesseling; Geertruida H de Bock
Journal:  Ann Surg Oncol       Date:  2007-04-24       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.